Patents by Inventor Yang-Sung SOHN

Yang-Sung SOHN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NANOPARTICLE CARRIERS OF ACTIVE AGENTS FUNCTIONALIZED BY STIMULI-RESPONSIVE CONJUGATION WITH DNA-NANOSTRUCTURES, METHODS OF THEIR PREPARATIONS, COMPOSITIONS COMPRISING THEM AND USES THEREOF
    Publication number: 20240082169
    Abstract: The present invention provides nanoparticle carriers of active agents which are functionalized by stimuli-responsive conjugation with DNA-nano structures, methods and processes for their preparation, compositions comprising them and uses thereof in methods of treating diseases, disorders and symptoms thereof.
    Type: Application
    Filed: January 17, 2022
    Publication date: March 14, 2024
    Applicant: Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
    Inventors: Itamar WILLNER, Eli PIKARSKY, Rachel NECHUSHTAI, Yang-Sung SOHN, Pu ZHANG, Yu OUYANG
  • NAF-1 derived peptides and uses thereof
    Patent number: 11208443
    Abstract: The present invention provides peptides comprising a sequence derived from the human NAF-1 protein, analogs of said sequence or a retro-inverso sequence of said peptide or analog. The conjugates of such peptides are provided as well. The peptides and the conjugates of the present invention are useful in treating cancer, and in particular cancer in which the expression of NAF-1 is enhanced.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: December 28, 2021
    Assignee: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
    Inventors: Rachel Nechushtai, Assaf Friedler, Anat Iosub-Amir, Merav Darash-Yahana, Yang-Sung Sohn, Dorit Michaeli
  • NAF-1 DERIVED PEPTIDES AND USES THEREOF
    Publication number: 20190375805
    Abstract: The present invention provides peptides comprising a sequence derived from the human NAF-1 protein, analogs of said sequence or a retro-inverso sequence of said peptide or analog. The conjugates of such peptides are provided as well. The peptides and the conjugates of the present invention are useful in treating cancer, and in particular cancer in which the expression of NAF-1 is enhanced.
    Type: Application
    Filed: February 12, 2018
    Publication date: December 12, 2019
    Inventors: Rachel NECHUSHTAI, Assaf FRIEDLER, Anat IOSUB-AMIR, Merav DARASH-YA-HANA, Yang-Sung SOHN, Dorit MICHAELI